Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China · Delayed Price · Currency is CNY 53.23
-0.71 (-1.32%)
At close: Feb 26, 2026
SHA:688193 Market Cap
SHA:688193 has a market cap or net worth of 2.1 billion as of February 27, 2026. Its market cap has increased by 65.13% in one year.
Market Cap
2.10B
Enterprise Value
1.32B
Revenue
165.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.23
Market Cap Chart
Since March 30, 2022, SHA:688193's market cap has decreased from 2.59B to 2.10B, a decrease of -18.82%. That is a compound annual growth rate of -5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 2.06B | 10.05% |
| Dec 31, 2025 | 1.88B | 35.54% |
| Dec 31, 2024 | 1.38B | -23.32% |
| Dec 29, 2023 | 1.80B | -3.42% |
| Dec 30, 2022 | 1.87B | -27.86% |
| Mar 30, 2022 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.12B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 7.19B |
| Cowealth Medical China | 6.68B |
| SMO ClinPlus CO.,LTD. | 5.33B |
| Thalys Medical Technology Group | 4.53B |
| Shanghai Labway Clinical Laboratory | 4.48B |
| Berry Genomics Co.,Ltd | 4.42B |